Companies / Evommune, Inc. / Activity
Activity — Evommune, Inc.
8 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Verduyn-van Weegen Felice Isabel Director | Grant | Common Stock | $10.00M | +359K +7.28% | 5,288,313 14.57% of shares | low |
| Feb 17, 2026 | LSP 7 Cooperatieve U.A. Director | Grant | Common Stock | $10.00M | +359K +7.28% | 5,288,313 14.57% of shares | low |
| Feb 17, 2026 | RA Capital Management, L.P. Director | Grant | Common Stock | $1000.0K | +36K +1.34% | 2,710,293 7.47% of shares | low |
| Jun 2, 2026 | Cohen David E Director | Sell | Common Stock | $110.3K | -5K -23.06% | 18,209 0.05% of shares | medium |
| Jun 2, 2026 | Cohen David E Director | Sell | Common Stock | $12.8K | -600 -3.30% | 17,609 0.05% of shares | low |
| Jun 2, 2026 | Cohen David E Director | Grant | Stock Option (Right to buy) | — | +16K | 15,673 0.04% of shares | low |
| Jun 2, 2026 | Kirsch Arthur S Director | Grant | Stock Option (Right to buy) | — | +16K | 15,673 0.04% of shares | low |
| Jun 2, 2026 | McGraw Benjamin F III Director | Grant | Stock Option (Right to buy) | — | +16K | 15,673 0.04% of shares | low |